Laboratory instruments and solutions provider Tecan Group has announced its decision to acquire sample preparation solutions provider SPEware Corporation for $50m.

Following the acquisition, SPEware will become part of Tecan's Life Sciences Business, enabling the company to expand its dedicated solutions offerings.

Sunovion Pharmaceuticals has announced the acquisition of pharmaceutical company Cynapsus Therapeutics for $624m.

"Sunovion Pharmaceuticals has announced the acquisition of pharmaceutical company Cynapsus Therapeutics for $624m."

Sunovion develops products for the central nervous system and respiratory disorders. The acquisition of Cynapsus is part of the company's global strategy to expand its portfolio.

Immuno-oncology company Leap Therapeutics has announced its plans to acquire biopharmaceutical company Macrocure. Both companies involved in the transaction are based in the US.

Macrocure will operate as a wholly owned subsidiary of Leap Therapeutics upon completion of the transaction.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The acquisition will enable the companies to advance the development of two first-in-class, immuno-oncology monoclonal antibodies targeting aggressive cancers.